InvestorsHub Logo
icon url

cruzanstcroix

06/07/11 8:05 AM

#6644 RE: cruzanstcroix #6643

I personally don't think his appointment will actually move the stock much, if at all, but it is encouraging to see that they're building a team that (on outward appearances at least) makes sense.

He played a key role in establishing a worldwide distribution network for the company's products which led to Diagnostic Products Corporation being listed several times by both Forbes Magazine and Business Week Magazine as one of the "Top 100 Growth Companies" and one of the "200 Best Small Companies in the U.S."

icon url

RonnieD

06/07/11 12:01 PM

#6660 RE: cruzanstcroix #6643

this is a great move, but as far as the stock goes
they are still going to have to allow the convertibles
to play out, because they don't have cash otherwise,
and are contractually obligated to do so.
expect a A/S raise to over current 1.5 Billion
and full accomodation of current toxic load,
then a reinstatement of the R/S plan. New CEO
is a NYSE-listed player, he will not waste time
with a .03 cent stock for long.. and that's a good thing
longer term, post-R/S.
It would likely be wise to wait for these things
to play out, rather than investing and riding through them.